We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Detection of JNK, p38 and MAPK Enzyme Activation Using Anti-Dual-Phosphopeptide...

Detection of JNK, p38 and MAPK Enzyme Activation Using Anti-Dual-Phosphopeptide Antibodies: Coordinated Signaling of the Extracellular Signal-Regulated Protein Kinase (ERK) Superfamily
  • Share
  • Print
  • Email
  • Download PDF

Abstract

The Extracellular Signal-Regulated Protein Kinase (ERK) superfamily is the focus of intensive study due to its widespread involvement in signaling pathways in both normal and disease states. Promega's Anti-ACTIVE™ MAPK, Anti-ACTIVE™ JNK and the soon to be released Anti-ACTIVE™ p38 pAbs provide researchers with a unique and rigorously tested panel of reagents to sort out the coordinated regulation of the ERK superfamily members. These antibodies can be used for a variety of non-radioactive applications, including Western blotting and immunocytochemistry, allowing a more accurate assessment of enzyme activation in response to a variety of extracellular stimuli.

Promega Notes 63, 2.

Bruce W. Jarvis1,  and Erik M. Schaefer1 and David T. Miller2

1Promega Corporation; 2Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO
Publication Date: 1997

Download Article (263 KB)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.